mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland [letter].

Hilty, Matthias Peter; Keiser, Stefanie; Wendel Garcia, Pedro D; Moser, André; Schuepbach, Reto A (2022). mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland [letter]. Intensive care medicine, 48(3), pp. 362-365. Springer-Verlag 10.1007/s00134-021-06610-z

Text
Hilty_IntensiveCareMed_2022.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (541kB) | Request a copy

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)
UniBE Contributor:	Moser, André
ISSN:	0342-4642
Publisher:	Springer-Verlag
Language:	English
Submitter:	Andrea Flükiger-Flückiger
Date Deposited:	27 Jan 2022 16:01
Last Modified:	20 Feb 2024 14:16
Publisher DOI:	10.1007/s00134-021-06610-z
PubMed ID:	35050384
BORIS DOI:	10.48350/164855
URI:	https://boris.unibe.ch/id/eprint/164855

Actions (login required)

Edit item

mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland [letter].

Interest & Impact

Downloads

Citations

Search

Services

Actions (login required)

Item Type:

Division/Institute:

UniBE Contributor:

ISSN:

Publisher:

Language:

Submitter:

Date Deposited:

Last Modified:

Publisher DOI:

PubMed ID:

BORIS DOI:

URI:

Actions (login required)